Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis.
Multidrug resistant (MDR) tuberculosis is caused by Mycobacterium tuberculosis resistant to isoniazid and rifampicin, the two most effective drugs used in tuberculosis therapy. Here, we investigated the mechanism by which resistance towards isoniazid develops and how overexpression of efflux pumps f...
Guardado en:
Autores principales: | Diana Machado, Isabel Couto, João Perdigão, Liliana Rodrigues, Isabel Portugal, Pedro Baptista, Bruno Veigas, Leonard Amaral, Miguel Viveiros |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2d3b170685344caea5d7def9047f6f1c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Drug Resistance in Mycobacterium Tuberculosis Isolates to Isoniazid and Rifampin
por: M Pourhajibagher, et al.
Publicado: (2012) -
LOOKING INSIDE THE FOREST: FROM CLASSICAL GENOTYPING OF MYCOBACTERIUM TUBERCULOSIS TO WHOLE GENOME SEQUENCING IN HIGH MULTIDRUG RESISTANCE SETTINGS
por: J. Perdigão
Publicado: (2018) -
Isoniazid inhibits the heme-based reactivity of Mycobacterium tuberculosis truncated hemoglobin N.
por: Paolo Ascenzi, et al.
Publicado: (2013) -
The Effects Study of Isoniazid Conjugated Multi-Wall Carbon Nanotubes Nanofluid on Mycobacterium tuberculosis
por: Zomorodbakhsh S, et al.
Publicado: (2020) -
Genetic diversity of candidate loci linked to Mycobacterium tuberculosis resistance to bedaquiline, delamanid and pretomanid
por: Paula J. Gómez-González, et al.
Publicado: (2021)